BioSpace News Archive

Frost & Sullivan Announces Cutting Edge Life Sciences Research on the Horizon

April 3, 2012
·
3 min read
Drug Development

TetraLogic Pharmaceuticals Announces Presentation of Preclinical Data on Birinapant (TL32711) in Pancreatic Cancer and Lymphoma at the 103rd American Association for Cancer Research Annual Meeting 2012

April 3, 2012
·
1 min read
AEterna Zentaris Presents Preclinical Data for Its Anti-Cancer PI3K/ Erk 1/2 Inhibitor, AEZS-136, at American Association for Cancer Research Meeting

April 3, 2012
·
4 min read
Policy

Astellas Pharma Inc. Overactive Bladder Drug Raises Blood Pressure Dangers, FDA Says

April 3, 2012
·
1 min read
Drug Development

Johnson & Johnson Alzheimer’s Med Cut Chemical Tied to Brain Tangles

April 3, 2012
·
1 min read
FDA

Quidel Corporation Receives CE Mark for Its Direct Specimen Rapid PCR Test for Toxigenic Clostridium Difficile

April 3, 2012
·
5 min read
Pharm Country

PhotoMedex, Inc. Release: Over One Million NEOVA® DNA Damage Control SILC SHEER Sold

April 3, 2012
·
4 min read
Aerocrine: Notice of Annual General Meeting

April 3, 2012
·
1 min read
Drug Development

CureFAKtor Pharmaceuticals. LLC Demonstrates Novel Focal Adhesion Kinase (FAK) Inhibitor Disrupts FAK-VEGFR3 Interaction and Inhibits Pancreatic Tumor Growth

April 3, 2012
·
3 min read
Drug Development

Unigene Laboratories, Inc.'s Proprietary Oral Peptide Delivery Platform is Further Validated with Cara Therapeutics’ Successful Completion of its Phase 1 Study Using Unigene’s Oral Formulation of Novel Kappa Opioid Receptor Agonist, CR845

April 3, 2012
·
7 min read